SMP-656 - Chengdu Kelingyuan Pharma
https://oncologypro.esmo.org/congress-resources/esmo-asia-congress-2025?presentation=phase_i_ib_data_of_smp_656__a_novel_eribulin_based
 
J. Zhang1; Y. Shi2; Y. Chen3; Y. Gao4; Y. Du1; J. Lin3; J. Liu5; X. Liu1; Y. Liu5; C. Wu5; H. Li6; X. Liu6; R. Gao7; J. Huang7; X. Li7; Y. Cheng5
 
Oct 4, 2025
 
Next